Chongqing Taiji Industry (group) Co., Ltd. Class ASSE: 600129

Announcement on Obtaining Notice of Approval for Drug Clinical Trial of Semaglutide Injection

· Issued by Chongqing Taiji Industry (group) Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Obtaining Notice of Approval for Drug Clinical Trial of Semaglutide Injection

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis